Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Characterization of Actinomyces species isolated from failed dental implant fixtures.

Sarkonen N, Könönen E, Eerola E, Könönen M, Jousimies-Somer H, Laine P.

Anaerobe. 2005 Aug;11(4):231-7. Epub 2005 Apr 7.

PMID:
16701573
2.

Porphyromonas uenonis sp. nov., a pathogen for humans distinct from P. asaccharolytica and P. endodontalis.

Finegold SM, Vaisanen ML, Rautio M, Eerola E, Summanen P, Molitoris D, Song Y, Liu C, Jousimies-Somer H.

J Clin Microbiol. 2004 Nov;42(11):5298-301.

3.

Bacteremia after plate removal and tooth extraction.

Rajasuo A, Nyfors S, Kanervo A, Jousimies-Somer H, Lindqvist C, Suuronen R.

Int J Oral Maxillofac Surg. 2004 Jun;33(4):356-60.

PMID:
15145038
4.

Bacteremia following surgical dental extraction with an emphasis on anaerobic strains.

Rajasuo A, Perkki K, Nyfors S, Jousimies-Somer H, Meurman JH.

J Dent Res. 2004 Feb;83(2):170-4.

PMID:
14742658
5.

Evaluation of four commercial test systems for identification of actinomyces and some closely related species.

Santala AM, Sarkonen N, Hall V, Carlson P, Jousimies-Somer H, Könönen E.

J Clin Microbiol. 2004 Jan;42(1):418-20.

6.

Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance.

Harmoinen J, Mentula S, Heikkilä M, van der Rest M, Rajala-Schultz PJ, Donskey CJ, Frias R, Koski P, Wickstrand N, Jousimies-Somer H, Westermarck E, Lindevall K.

Antimicrob Agents Chemother. 2004 Jan;48(1):75-9.

7.

Actinobacillus actinomycetemcomitans and Haemophilus aphrophilus in systemic and nonoral infections in Finland.

Paju S, Carlson P, Jousimies-Somer H, Asikainen S.

APMIS. 2003 Jun;111(6):653-7.

PMID:
12969021
8.

Age-related frequency of penicillin resistance of oral Veillonella.

Nyfors S, Könönen E, Bryk A, Syrjänen R, Jousimies-Somer H.

Diagn Microbiol Infect Dis. 2003 Aug;46(4):279-83.

PMID:
12944020
9.

Nasopharyngeal carriage of anaerobes during health and acute otitis media by two years of age.

Könönen E, Syrjänen R, Takala A, Jousimies-Somer H.

Diagn Microbiol Infect Dis. 2003 Jul;46(3):167-72.

PMID:
12867091
10.

Reclassification of Bacteroides putredinis (Weinberg et al., 1937) in a new genus Alistipes gen. nov., as Alistipes putredinis comb. nov., and description of Alistipes finegoldii sp. nov., from human sources.

Rautio M, Eerola E, Väisänen-Tunkelrott ML, Molitoris D, Lawson P, Collins MD, Jousimies-Somer H.

Syst Appl Microbiol. 2003 Jun;26(2):182-8.

PMID:
12866844
11.

Susceptibilities of different Actinobacillus actinomycetemcomitans strains to lactoperoxidase-iodide-hydrogen peroxide combination and different antibiotics.

Ihalin R, Pienihäkkinen K, Lenander M, Tenovuo J, Jousimies-Somer H.

Int J Antimicrob Agents. 2003 May;21(5):434-40.

PMID:
12727076
12.
13.

Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood.

Nyfors S, Könönen E, Syrjänen R, Komulainen E, Jousimies-Somer H.

J Antimicrob Chemother. 2003 Jan;51(1):107-12.

PMID:
12493794
14.

Establishment of streptococci in the upper respiratory tract: longitudinal changes in the mouth and nasopharynx up to 2 years of age.

Könönen E, Jousimies-Somer H, Bryk A, Kilp T, Kilian M.

J Med Microbiol. 2002 Sep;51(9):723-30.

PMID:
12358062
15.

A newborn with domestically acquired legionnaires disease confirmed by molecular typing.

Skogberg K, Nuorti JP, Saxen H, Kusnetsov J, Mentula S, Fellman V, Mäki-Petäys N, Jousimies-Somer H.

Clin Infect Dis. 2002 Oct 15;35(8):e82-5. Epub 2002 Sep 19.

PMID:
12355396
16.
17.

Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults.

Finegold SM, Flynn MJ, Rose FV, Jousimies-Somer H, Jakielaszek C, McTeague M, Wexler HM, Berkowitz E, Wynne B.

Clin Infect Dis. 2002 Aug 15;35(4):428-33. Epub 2002 Jul 24.

PMID:
12145727
18.

Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis.

Väkeväinen S, Mentula S, Nuutinen H, Salmela KS, Jousimies-Somer H, Färkkilä M, Salaspuro M.

Scand J Gastroenterol. 2002 Jun;37(6):648-55.

PMID:
12126241
19.

gyrA polymorphism in Campylobacter jejuni: detection of gyrA mutations in 162 C. jejuni isolates by single-strand conformation polymorphism and DNA sequencing.

Hakanen A, Jalava J, Kotilainen P, Jousimies-Somer H, Siitonen A, Huovinen P.

Antimicrob Agents Chemother. 2002 Aug;46(8):2644-7.

20.

Matrilysin (matrix metalloproteinase-7) expression in human junctional epithelium.

Uitto VJ, Salonen JI, Firth JD, Jousimies-Somer H, Saarialho-Kere U.

J Dent Res. 2002 Apr;81(4):241-6.

PMID:
12097307
21.

Quality control strains used in susceptibility testing of Campylobacter spp.

Hakanen A, Huovinen P, Kotilainen P, Siitonen A, Jousimies-Somer H.

J Clin Microbiol. 2002 Jul;40(7):2705-6. No abstract available.

22.

Characterisation of aerobic gram-negative bacteria from subgingival sites of dogs--potential bite wound pathogens.

Forsblom B, Sarkiala-Kessel E, Kanervo A, Väisänen ML, Helander M, Jousimies-Somer H.

J Med Microbiol. 2002 Mar;51(3):207-20.

PMID:
11871615
23.

[Peritonsillar abscess, its causes and modern treatment].

Savolainen S, Jousimies-Somer H.

Duodecim. 1998;114(18):1843-8. Review. Finnish. No abstract available.

PMID:
11717767
24.

Characterisation of Eubacterium-like strains isolated from oral infections.

Downes J, Munson MA, Spratt DA, Kononen E, Tarkka E, Jousimies-Somer H, Wade WG.

J Med Microbiol. 2001 Nov;50(11):947-51.

PMID:
11699590
25.

Phenotypic identification of Actinomyces and related species isolated from human sources.

Sarkonen N, Könönen E, Summanen P, Könönen M, Jousimies-Somer H.

J Clin Microbiol. 2001 Nov;39(11):3955-61.

26.

Differences between patients with or without the need for intensive care due to severe odontogenic infections.

Ylijoki S, Suuronen R, Jousimies-Somer H, Meurman JH, Lindqvist C.

J Oral Maxillofac Surg. 2001 Aug;59(8):867-72; discussion 872-3.

PMID:
11474438
27.

Acetaldehyde production and other ADH-related characteristics of aerobic bacteria isolated from hypochlorhydric human stomach.

Väkeväinen S, Tillonen J, Blom M, Jousimies-Somer H, Salaspuro M.

Alcohol Clin Exp Res. 2001 Mar;25(3):421-6.

PMID:
11290854
28.

The Prevotella intermedia group organisms in young children and their mothers as related to maternal periodontal status.

Könönen E, Wolf J, Mättö J, Frandsen EV, Poulsen K, Jousimies-Somer H, Asikainen S.

J Periodontal Res. 2000 Dec;35(6):329-34.

PMID:
11144405
29.

Bacteriology of histopathologically defined appendicitis in children.

Rautio M, Saxén H, Siitonen A, Nikku R, Jousimies-Somer H.

Pediatr Infect Dis J. 2000 Nov;19(11):1078-83.

PMID:
11099090
30.

Acetaldehyde production and metabolism by human indigenous and probiotic Lactobacillus and Bifidobacterium strains.

Nosova T, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M.

Alcohol Alcohol. 2000 Nov-Dec;35(6):561-8.

PMID:
11093962
31.

Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol.

Väkeväinen S, Tillonen J, Salaspuro M, Jousimies-Somer H, Nuutinen H, Färkkilä M.

Aliment Pharmacol Ther. 2000 Nov;14(11):1511-8.

32.

Metronidazole increases intracolonic but not peripheral blood acetaldehyde in chronic ethanol-treated rats.

Tillonen J, Väkeväinen S, Salaspuro V, Zhang Y, Rautio M, Jousimies-Somer H, Lindros K, Salaspuro M.

Alcohol Clin Exp Res. 2000 Apr;24(4):570-5.

PMID:
10798595
33.

Oral colonization with Actinomyces species in infants by two years of age.

Sarkonen N, Könönen E, Summanen P, Kanervo A, Takala A, Jousimies-Somer H.

J Dent Res. 2000 Mar;79(3):864-7.

PMID:
10765961
34.

Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer.

Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, Jousimies-Somer H, Salaspuro M.

Carcinogenesis. 2000 Apr;21(4):663-8.

PMID:
10753201
35.

Age, dental infections, and coronary heart disease.

Mattila KJ, Asikainen S, Wolf J, Jousimies-Somer H, Valtonen V, Nieminen M.

J Dent Res. 2000 Feb;79(2):756-60.

PMID:
10728977
36.

Altered antigenicity is seen in the lipopolysaccharide profile of non-serotypeable Actinobacillus actinomycetemcomitans strains.

Paju S, Saarela M, Chen C, Jousimies-Somer H, Uitto V, Asikainen S.

FEMS Immunol Med Microbiol. 2000 Feb;27(2):171-7.

38.

Microbiology terminology update: clinically significant anaerobic gram-positive and gram-negative bacteria (excluding spirochetes).

Jousimies-Somer H, Summanen P.

Clin Infect Dis. 1999 Oct;29(4):724-7. No abstract available.

PMID:
10589876
39.

Ethanol oxidation and acetaldehyde production in vitro by human intestinal strains of Escherichia coli under aerobic, microaerobic, and anaerobic conditions.

Salaspuro V, Nyfors S, Heine R, Siitonen A, Salaspuro M, Jousimies-Somer H.

Scand J Gastroenterol. 1999 Oct;34(10):967-73.

PMID:
10563665
40.

Establishment of oral anaerobes during the first year of life.

Könönen E, Kanervo A, Takala A, Asikainen S, Jousimies-Somer H.

J Dent Res. 1999 Oct;78(10):1634-9.

PMID:
10520968
41.

Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents.

Mättö J, Asikainen S, Väisänen ML, Von Troil-Lindén B, Könönen E, Saarela M, Salminen K, Finegold SM, Jousimies-Somer H.

Antimicrob Agents Chemother. 1999 Oct;43(10):2383-8.

42.

Age-related acquisition of oral and nasopharyngeal yeast species and stability of colonization in young children.

Hannula J, Saarela M, Jousimies-Somer H, Takala A, Syrjänen R, Könönen E, Asikainen S.

Oral Microbiol Immunol. 1999 Jun;14(3):176-82.

PMID:
10495712
43.

Role of yeasts in the salivary acetaldehyde production from ethanol among risk groups for ethanol-associated oral cavity cancer.

Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M.

Alcohol Clin Exp Res. 1999 Aug;23(8):1409-15.

PMID:
10470985
44.

Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG.

Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M.

Clin Infect Dis. 1999 May;28(5):1159-60. No abstract available.

PMID:
10452653
45.

Beta-lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy.

Nyfors S, Könönen E, Takala A, Jousimies-Somer H.

Antimicrob Agents Chemother. 1999 Jul;43(7):1591-4.

46.

beta-lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.

Könönen E, Kanervo A, Salminen K, Jousimies-Somer H.

Antimicrob Agents Chemother. 1999 May;43(5):1270-3.

47.

Actinobacillus actinomycetemcomitans serotype e--biotypes, genetic diversity and distribution in relation to periodontal status.

Doğan B, Saarela MH, Jousimies-Somer H, Alaluusua S, Asikainen S.

Oral Microbiol Immunol. 1999 Apr;14(2):98-103.

PMID:
10219168
48.

Ciprofloxacin administration decreases enhanced ethanol elimination in ethanol-fed rats.

Nosova T, Jokelainen K, Kaihovaara P, Väkeväinen S, Rautio M, Jousimies-Somer H, Salaspuro M.

Alcohol Alcohol. 1999 Jan-Feb;34(1):48-54.

PMID:
10075401
49.

Ciprofloxacin decreases the rate of ethanol elimination in humans.

Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M.

Gut. 1999 Mar;44(3):347-52.

Supplemental Content

Loading ...
Support Center